Veterinary Medicines

Carepen vet 600 mg intramammary suspension for lactating cows

Authorised
  • Benzylpenicillin procaine monohydrate
Download as PDF

Product identification

Medicine name:
Carepen vet 600 mg intramammary suspension for lactating cows
UBROPEN 600 mg sospensione intramammaria per vacche in lattazione
Active substance:
  • Benzylpenicillin procaine monohydrate
Target species:
  • Cattle (lactating cow)
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Benzylpenicillin procaine monohydrate
    600.00
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (lactating cow)
      • Meat and offal
        3
        day
      • Milk
        6
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51CE09
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:
  • Pack size: 100 x 10 g with 100 cleaning towels. White intramammary syringe (LDPE) with a double tip (LDPE) packed in a cardboard container.
  • Pack size: 40 x 10 g with 40 cleaning towels. White intramammary syringe (LDPE) with a double tip (LDPE) packed in a cardboard container.
  • Pack size: 20 x 10 g with 20 cleaning towels. White intramammary syringe (LDPE) with a double tip (LDPE) packed in a cardboard container.
  • Pack size: 5 x 10 g with 5 cleaning towels. White intramammary syringe (LDPE) with a double tip (LDPE) packed in a cardboard container.
  • Pack size: 3 x 10 g with 3 cleaning towels. White intramammary syringe (LDPE) with a double tip (LDPE) packed in a cardboard container.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Vetcare Oy
Marketing authorisation date:
Manufacturing sites for batch release:
  • aniMedica GmbH
  • KELA Kempisch Laboratorium Kela Laboratoria
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 104713
Date of authorisation status change:
Reference member state:
  • Finland
Procedure number:
  • FI/V/0110/001
Concerned member states:
  • Austria
  • Belgium
  • Denmark
  • Estonia
  • France
  • Germany
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Norway
  • Poland
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 24/09/2025
Download

Package Leaflet

English (PDF)
Published on: 24/09/2025
Download

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 14/03/2022
Download

Labelling

English (PDF)
Published on: 24/09/2025
Download